Evidence map›Paper›PMID 38683400›Full record

ArticleEuropean child & adolescent psychiatry2025

Treatment patterns of antidepressants in children and adolescents in Scandinavia.

Lotte Rasmussen, Peter Bjødstrup Jensen, Johan Reutfors, Kari Furu, Svetlana Skurtveit, Randi Selmer, Per Damkier, Mette Bliddal, Rikke Wesselhoeft

Abstract read
In one paragraph

Article in European child & adolescent psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lotte RasmussenClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, JB Winsløws Vej 19, 5000, Odense, Denmark. lorasmussen@health.sdu.dk.ORCID http://orcid.org/0000-0001-5962-6647
Peter Bjødstrup JensenClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, JB Winsløws Vej 19, 5000, Odense, Denmark.
Johan ReutforsCentre for Pharmacoepidemiology, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-1372-4262
Kari FuruDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.ORCID http://orcid.org/0000-0003-2245-0179
Svetlana SkurtveitDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.ORCID http://orcid.org/0000-0001-7525-9701
Randi SelmerDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Per DamkierDepartment of Clinical Pharmacology, Odense University Hospital, 5000, Odense C, Denmark.ORCID http://orcid.org/0000-0003-0591-7187
Mette BliddalClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, JB Winsløws Vej 19, 5000, Odense, Denmark.ORCID http://orcid.org/0000-0002-7637-3730
Rikke WesselhoeftClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, JB Winsløws Vej 19, 5000, Odense, Denmark.ORCID http://orcid.org/0000-0001-9700-2739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to examine variations in use of antidepressants among children and adolescents in the three Scandinavian countries (Sweden, Norway, and Denmark). We identified new users of antidepressants (5-17 years) during 2007-2018 and described the annual incidence rate, treatment duration, concomitant psychotropic drug use, and the clinical setting of the prescribing physician (in Sweden and Denmark). Incident use of antidepressants increased by a factor 1.9 in Sweden, 1.3 in Norway and decreased by a factor 0.6 in Denmark during the study period. In Sweden, 58% of antidepressant users were covered by a prescription 12 months after initiation compared to 40% in Norway and 49% in Denmark. Also, 34% of Swedish antidepressant users were in continuous treatment after 12 months compared to 26% in Norway and 31% in Denmark. Concomitant use of other psychotropics was more common in Sweden (57%) than in Norway (37%) and Denmark (27%). During 2007-2018, clinicians from psychiatry settings initiated 75% of antidepressant treatments in Sweden, while this was the case for 50% of prescriptions in Denmark, although the proportion increased over time. The number of new antidepressant users is high and still rising in Sweden compared to Norway and Denmark. Swedish antidepressant users are more likely to use other psychotropics and to be covered by an antidepressant prescription after one year. Most antidepressants in Sweden are prescribed by physicians within psychiatric settings suggesting that they are based on specialized psychiatric evaluation.

Indexed as

Antidepressive AgentsDrug PrescriptionsPractice Patterns, Physicians'AdolescentChildChild, PreschoolDenmarkFemaleHumansMaleNorwayScandinavian and Nordic CountriesSwedenAntidepressive AgentsAntidepressantsChildren and adolescentsDenmarkDrug utilizationNorwaySweden

Identifiers

PMID38683400
PMCPMC11805761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.